Sign in

    Scott M. Brinker

    President and Chief Executive Officer at Healthpeak Properties Inc
    Board
    Since October 2022
    Age
    48 years
    Tenure
    Joined Healthpeak Properties, Inc. in March 2018 as Executive Vice President and Chief Investment Officer, was promoted to President and Chief Investment Officer in January 2020, and appointed President and Chief Executive Officer in October 2022.

    Also at Healthpeak Properties Inc

    AGM
    Adam G. Mabry
    Chief Investment Officer
    ABP
    Ankit B. Patadia
    Executive Vice President and Treasurer – Corporate Finance
    KOM
    Kelvin O. Moses
    Executive Vice President – Investments and Portfolio Management

    About

    Scott M. Brinker is a 48-year-old executive currently serving as the President and Chief Executive Officer of Healthpeak Properties, Inc. (ticker: DOC). He has extensive experience in the healthcare real estate investment trust (REIT) industry and has held multiple senior leadership roles since joining the company.

    Beginning his tenure as Executive Vice President and Chief Investment Officer in March 2018, he advanced to become President and Chief Investment Officer in January 2020, reflecting his growing responsibilities and expertise in corporate finance, asset management, and investor relations.

    In October 2022, he was appointed as President and Chief Executive Officer, a role in which he continues to drive strategic initiatives and operational excellence at Healthpeak Properties, Inc. His career has been further enriched by prior leadership roles at Welltower Inc. and his active involvement on the Executive Board of Nareit, underscoring a solid professional foundation in investment management and corporate strategy.

    $DOC Performance Under Scott M. Brinker

    Past Roles

    OrganizationRoleDate RangeDetails
    Healthpeak Properties, Inc. (DOC) President and Chief Investment Officer January 2020 – October 2022 Preceded appointment as President and CEO
    Healthpeak Properties, Inc. (DOC) Executive Vice President and Chief Investment Officer March 2018 – December 2019 Former role at DOC
    Welltower Inc. (NYSE: WELL) Executive Vice President and Chief Investment Officer July 2014 – January 2017 Held leadership role at a healthcare REIT
    Welltower Inc. (NYSE: WELL) Executive Vice President – Investments February 2012 – July 2014 Held multiple leadership roles at Welltower

    External Roles

    OrganizationRoleDate RangeDetails
    National Association of Real Estate Investment Trusts (Nareit) Executive Board Member N/A Active position outside of DOC

    Fixed Compensation

    Data from  FY 2024
    Component NameAmountPayment ScheduleAdditional Details
    Base Salary$750,000 Annual 2024Fixed base salary
    401(k) Matching Contribution$13,800 Annual 2024Matching contribution
    Broad-Based Employee Wellness Program$500 Annual 2024Employee wellness program
    Executive Medical Examination$4,200 Annual 2024Annual executive exam
    Executive Financial Planning Services$8,943 Annual 2024Financial planning services
    Retentive Stock Awards137,532 shares; Fair Value: $2,166,129 Grant Date 2024Stock award granted with specified fair value

    Performance Compensation

    Data from  FY 2024

    2024 Annual Cash Incentive Compensation

    MetricWeightTarget/OutcomePayout Details
    Normalized FFO Per Share55% (Financial Metrics)Outcome: $1.81 Payout at 183.3%
    Run-Rate Synergies55% (Financial Metrics)Outcome: $53.6 million Payout at 200%
    Corporate Impact Performance Metric15%Not quantified; evaluated on sustainability, culture, and governance criteria Impact-based payout

    Award Opportunity Levels:

    • Threshold (50%): $575,000
    • Target (100%): $1,150,000
    • High (150%): $1,725,000
    • Outperformance (200%): $2,041,250

    Additional Details:

    • Grant Date: February 16, 2024
    • Grant Date Fair Value: $3,548,277
    • Payouts are interpolated linearly between the defined levels with no bonus for performance below threshold

    2024 Performance-Based Awards

    Metric/ComponentTarget/ThresholdOutcome / AwardAdditional Details
    Net Debt to Adjusted EBITDAreThreshold: 6.0x; Target: 5.5x; High: 5.0xPayout moves from 0% at 6.0x to 200% at 5.0x Performance evaluated based on financial leverage
    Normalized FFO Per ShareMinimum hurdle: $1.30Outcome exceeded $1.30 Required for Retentive Awards
    TSR (Total Shareholder Return)Performance period: 2024 to 2026Payout range: 0% to 200% based on relative performance Evaluation over a 3-year period

    Shares Granted (Based on Performance):

    • Threshold: 103,148 shares
    • Target: 206,295 shares
    • Maximum: 412,590 shares

    Vesting Schedule & Conditions:

    • Awards vest at the end of the performance period on December 31, 2026
    • Vesting is contingent upon achieving the specified performance metrics for both financial and market-based measures

    Additional Information:

    • A Monte Carlo simulation was used to calculate the grant date fair value, incorporating a stock price volatility of 26.0% and a risk-free rate of 4.52%

    This table and explanation detail the performance compensation components, including required metrics, percentages, thresholds, targets, vesting conditions, and evaluation periods for 2024.